Companies

Alkem Laboratories Share Price Sees 2.5x Volume Spike Today — Volumes, 52-Week Range and What to Watch Next

Quick answer

Alkem Laboratories (ALKEM) trades at ₹5,175.00, +14.00 (+0.27%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.

TrendRipperX Data DeskPublished 16 Sept 2026, 9:05 pmUpdated 16 Sept 2026, 11:35 pm 7 min read
Share Share
Alkem Laboratories Share Price Sees 2.5x Volume Spike Today — Volumes, 52-Week Range and What to Watch Next

Quick summary

Last price

₹5,175.00

+0.27%

Day range

₹5,148.00 – ₹5,265.50

52-week high

₹5,934

Why ALKEM is being traded today

The in focus story around Alkem Laboratories (ALKEM) has the stock at ₹5,175.00, +0.27% on the session, with the NSE board read at 02:35 am IST on 17 September 2026. What the tape shows: the notable number today is turnover rather than price — volume at 2.5 times the twenty-day average means larger hands are transacting, and price usually follows participation.

Key takeaways

  • Where it trades: Alkem Laboratories is at ₹5,175.00, +14.00 (+0.27%) versus the previous close of ₹5,175.00.
  • Why it is moving: an in-focus story — one business desk filed on the company in the last few hours.
  • Today's band: ₹5,148.00 to ₹5,265.50, against an open of ₹5,170.50 — the stock is defending its opening print.
  • Twelve-month context: 12.78% below the ₹5,934 high and 2.45% above the ₹5,051 low, so the stock sits in the lower part of its own range.
  • Participation: turnover is running at 2.5x the twenty-day average, so institutions are transacting rather than retail nibbling.
  • What to watch: an exchange filing from the company itself, since headline-driven moves without a disclosure behind them tend to fade within a session or two.

Why Alkem Laboratories is on the desks today

Alkem Laboratories is one of the most-mentioned names on the business wires right now — reported by one desk so far, with the headlines linked below. When several desks run the same company on the same day, the flow that follows is usually driven by attention rather than by a single disclosure, so the price move needs volume behind it to mean anything.

Today's quote in numbers

FieldValue
Last price₹5,175.00
Change+14.00 (+0.27%)
Open₹5,170.50
Day range₹5,148.00 – ₹5,265.50
Previous close₹5,175.00
Volume3,04,188
52-week range₹5,051 – ₹5,934
20-day average volume1,23,977

What it means when several desks run the same name

A publisher filed on Alkem Laboratories in the last few hours without a single dominant disclosure driving it. Clustered coverage of this kind is usually attention rather than information: a screen result, a sector read-across, or a follow-up to something filed earlier in the week. Attention brings order flow, but order flow without a disclosure behind it decays.

The way to separate the two is participation. A move on turnover at or above the stock's own recent average means positions are changing hands and the level is likely to hold. The same move on thin volume is a handful of trades and reverses easily, which is why the volume column deserves as much attention as the percentage change.

Alkem Laboratories is at ₹5,175.00, +14.00 (+0.27%), between ₹5,148.00 and ₹5,265.50 on the day, on 2.5x its twenty-day average volume.

Coverage across the desks

Headlines are listed for context and link straight to the publisher. The prices, ranges and tables on this page are read independently from exchange data at the timestamp shown.

What the tape is saying

Alkem Laboratories has traded between ₹5,148.00 and ₹5,265.50 in this session against an open of ₹5,170.50 and a previous close of ₹5,175.00. That is a band of ₹117.50, or 2.27% of the current price — an ordinary day's spread, so the move is orderly rather than disorderly.

Holding above the open at ₹5,170.50 matters because it is the level intraday desks use as the session pivot: buyers who entered at the open are in profit, so there is no forced supply from that cohort.

In market-structure terms this is a participation event: price has done little but turnover has not, which historically precedes the move rather than following it.

Performance across horizons

PeriodReturn
1W-1.29%
1M-3.60%
3M-3.23%
6M-6.66%
1Y-5.96%

What the returns table is saying

Over the last week Alkem Laboratories has slipped -1.29% and over the month -3.60%. Both horizons pointing the same way means the recent move is an extension of the existing trend rather than a reversal.

The twelve-month return of -5.96% is the context long-term holders judge the stock on. A moderate one-year move means the stock has broadly tracked its earnings path rather than being re-rated in either direction.

Reading the price against its own ranges

Over the last twelve months the price has covered ₹5,051 to ₹5,934. The current level is 14% of the way through that band, 12.78% below the 52-week high and 2.45% above the 52-week low. Sitting this close to the yearly low means every rally has to work through investors waiting to exit at break-even, which is why bases near the low take time to form.

Traded quantity of 3,04,188 shares is 2.45x the 20-day average of 1,23,977. Volume expansion of this order alongside a price move is the classic confirmation signal — institutions cannot build or exit positions quietly, so unusual turnover normally means larger hands are active.

Where this goes from here

For this in focus story specifically, watch an exchange filing from the company itself, since headline-driven moves without a disclosure behind them tend to fade within a session or two. On the chart, the ₹5,265.50 high and ₹5,148.00 low of this session are the reference levels — a higher low in the next session turns a headline reaction into a trend, a break of today's low usually voids it. Participation is the third check: the move needs turnover at or above the stock's own 20-day average of 1,23,977 shares to be read as positioning rather than a squeeze.

Trader's view versus investor's view

For a trader, price is the less interesting number today. Turnover at 2.5x the twenty-day average with a small price change usually means accumulation or distribution in progress, and the direction reveals itself when the range finally breaks.

For a long-term shareholder, one session tells you very little. The stock is 12.78% off its twelve-month high, so the more useful exercise is comparing that drawdown with the change in earnings over the same period: price falling faster than profits is an opportunity, the reverse is a warning.

On risk: this report is a reading of live exchange data at a point in time, and intraday levels change. Position sizing — not conviction about the story — is what determines the outcome of a trade built on a headline, and averaging into a falling price without a change in the underlying facts is how a trade becomes an unintended long-term holding.

Our read

Alkem Laboratories is being bought on an in-focus story, and at ₹5,175.00 the move is backed by turnover well above its own average, which is the version of a rally that tends to hold. The day's ₹5,148.00–₹5,265.50 band is the frame for the next session, and an exchange filing from the company itself is what resolves the story either way.

Where to track ALKEM next

Live price, charts and technicals stay on the Alkem Laboratories stock page, and every filed quarter is tabulated on its quarterly results page. Both pages refresh from the exchange feed through the session, so they carry a later reading than this report once the market has moved on.

Frequently asked questions

What is the Alkem Laboratories share price today?

Alkem Laboratories (ALKEM) last traded at ₹5,175.00, +14.00 (+0.27%) against the previous close of ₹5,175.00, read from the NSE board at 02:35 am IST on 17 September 2026.

Why is Alkem Laboratories in the news today?

1 business publisher ran headlines on the company in the last session — a in focus story. Their reports are linked above; the levels and tables here are read independently from exchange data.

What is the 52-week high and low of ALKEM?

Over the last twelve months ALKEM has traded between a low of ₹5,051 and a high of ₹5,934, computed from the adjusted daily series.

Is ALKEM up or down today?

ALKEM gained +0.27% in this session, trading between ₹5,148.00 and ₹5,265.50 against an open of ₹5,170.50.

Key takeaways

  • Last price: ₹5,175.00 (+0.27%) — higher at the time of writing
  • Day range: ₹5,148.00 – ₹5,265.50
  • 52-week high: ₹5,934

About this report

Every figure on this page is read from a primary source at the timestamp shown — exchange boards for equities and indices, the exchange bid book for IPOs, published association rates for bullion, and consolidated exchange quotes for crypto — with no estimation or third-party commentary. Historical fields such as trailing returns and 52-week extremes are computed on the adjusted daily series so splits and bonuses do not create false gaps. A timestamp outside market hours reflects the last traded or last published value, not a live tick.

Sources

This report is generated automatically from live exchange and official association data at the time stamped above. Prices move continuously — verify on the source before acting. Nothing here is investment advice.

Editorial desk
#Alkem Laboratories#ALKEM#In Focus#Share Price#Stocks in News#NSE

Frequently asked questions

What has changed for ALKEM?

Alkem Laboratories (ALKEM) trades at ₹5,175.00, +14.00 (+0.27%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.

Why ALKEM is being traded today?

The in focus story around Alkem Laboratories (ALKEM) has the stock at ₹5,175.00, +0.27% on the session, with the NSE board read at 02:35 am IST on 17 September 2026.

What does key takeaways mean for investors?

Where it trades: Alkem Laboratories is at ₹5,175.00, +14.00 (+0.27%) versus the previous close of ₹5,175.00. Why it is moving: an in-focus story — one business desk filed on the company in the last few hours. Today's band: ₹5,148.00 to ₹5,265.50, against an open of ₹5,170.50 — the stock is defending its opening print.

Why Alkem Laboratories is on the desks today?

Alkem Laboratories is one of the most-mentioned names on the business wires right now — reported by one desk so far, with the headlines linked below.

What it means when several desks run the same name?

A publisher filed on Alkem Laboratories in the last few hours without a single dominant disclosure driving it. Clustered coverage of this kind is usually attention rather than information: a screen result, a sector read-across, or a follow-up to something filed earlier in the week.

How significant is coverage across the desks?

Headlines are listed for context and link straight to the publisher. The prices, ranges and tables on this page are read independently from exchange data at the timestamp shown. Alkem Laboratories launches NeuCeno for partial-onset seizures in adults — The Hindu BusinessLine.

Comments

Comments are moderated. Be civil, no stock tips or promotions.

Sign in to join the discussion.

Loading comments…

Related articles

Newsletter

Get the next earnings decode in your inbox